Literature DB >> 14752775

Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens.

Liang-Piu Koh1, Nelson J Chao.   

Abstract

Unrelated umbilical cord blood (UCB) transplantation has recently been explored in an increasing number of adult patients. The relative ease of procurement and the lower-than-anticipated risk of severe acute graft-versus-host disease has made UCB transplantation an appealing alternative to bone marrow-derived hematopoietic stem cells. The use of reduced-intensity or nonmyeloablative preparative regimens to allow engraftment of UCB broadens the scope of patients who may benefit from allogeneic immunotherapy, including elderly and medically infirm patients with no matched sibling donor. This review summarizes the available data on the use of UCB as an alternative source of hematopoietic stem cell transplantation in adult patients.

Entities:  

Mesh:

Year:  2004        PMID: 14752775     DOI: 10.1016/j.bbmt.2003.09.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  13 in total

1.  In silico analyses of proteomic data suggest a role for heat shock proteins in umbilical cord blood hematopoietic stem cells.

Authors:  Angelo D'Alessandro; Giuliano Grazzini; Bruno Giardina; Lello Zolla
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

2.  Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

Authors:  Karen K Ballen; Thomas R Spitzer; Beow Y Yeap; Steven McAfee; Bimalangshu R Dey; Eyal Attar; Richard Haspel; Grace Kao; Deborah Liney; Edwin Alyea; Stephanie Lee; Corey Cutler; Vincent Ho; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

Review 3.  Hematopoietic stem cell transplantation for MDS.

Authors:  Matthias Bartenstein; H Joachim Deeg
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

4.  T-lymphocyte recovery and function after cord blood transplantation.

Authors:  Paul Szabolcs
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

5.  Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.

Authors:  Mahito Misawa; Shunro Kai; Masaya Okada; Toshiyuki Nakajima; Kaori Nomura; Takeshi Wakae; Akinari Toda; Hisayuki Itoi; Hiroyuki Takatsuka; Takeyoshi Itsukuma; Keisuke Nishioka; Yoshihiro Fujimori; Hiroyasu Ogawa; Hiroshi Hara
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

6.  Advances in cord blood transplants in adults.

Authors:  Phuong L Doan; Nelson J Chao
Journal:  F1000 Med Rep       Date:  2010-02-11

Review 7.  Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom?

Authors:  Mario Marcondes; H Joachim Deeg
Journal:  Best Pract Res Clin Haematol       Date:  2008-03       Impact factor: 3.020

Review 8.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486

Review 9.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

Review 10.  Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?

Authors:  Boglarka Gyurkocza; H Joachim Deeg
Journal:  Blood Rev       Date:  2012-09-13       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.